Lucid Diagnostics Inc. (LUCD) stock
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3025% above fair value
$0.37−0.01 (-3.52%)
Close on Nov 20, 2026Market cap $75.75MP/E –Yield –
Lucid Diagnostics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Lucid Diagnostics's gross profit for the twelve months ending Dec 31, 2022 was $377.00K, down 24.6% year over year. For fiscal 2025 it was -$1.96M.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.96M | – |
| FY2024 | Dec 31, 2024 | -$2.75M | -830.2% |
| FY2022 | Dec 31, 2022 | $377.00K | -24.6% |
| FY2021 | Dec 31, 2021 | $500.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $29.00K | -74.1% |
| Q1 FY2026 | Mar 31, 2026 | -$369.00K | -585.5% |
| Q2 FY2025 | Jun 30, 2025 | -$400.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$723.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $112.00K | -62.7% |
| Q3 FY2022 | Sep 30, 2022 | $76.00K | -62.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | -$180.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $300.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $200.00K | – |
See a number that looks wrong?